Key Highlights

• Annual Recurring Revenue (ARR) reached $14 million at 1 July 2026, up 21% year on year, with ARR growing to represent 50% of Adjusted Revenue in FY26.
• Adjusted EBITDA of $6.9 million exceeded the IPO Prospectus forecast of $6.6 million, while Adjusted NPAT came in at $6.5 million.
• The company ended the year with Pro Forma Cash of $11.1 million and Pro Forma Debt of $6.0 million following completion of its ASX listing.
• Monvia renewed its largest client, MetLife, on a five-year contract with improved terms, while completing the Acquisition of Monvia Australia Pty Ltd and listing on the ASX during the period.

Monvia Limited (ASX:MNV) shares were unchanged after the…